Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care Sites
Katerina Christopoulos, Jonathan Colasanti, Mallory O. Johnson, Manami Diaz Tsuzuki, Xavier A. Erguera, Rey Flores, Jared Kerman, Kaylin V. Dance, John A. Sauceda, Torsten B. Neilands, Samantha E. Dilworth, Kimberly A. Koester, José I. Gutierrez, John A. Schneider, Elizabeth Montgomery, Moira McNulty
Abstract
Use of long-acting injectable antiretroviral therapy depends on patient awareness, provider discussion, and patient willingness to use. We conducted a postvisit survey with patients at 3 HIV clinics in San Francisco, Chicago, and Atlanta in May 2021 to assess for inequities in these early implementation phases.
Topics & Concepts
MedicineAntiretroviral therapyHuman immunodeficiency virus (HIV)Family medicineViral loadHIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskLGBTQ Health, Identity, and Policy